Medi Caps logo

Medi Caps Q1 results, quarter to Jun 2026

NSE: MEDICAPQBSE: 523144Pharmaceuticals & BiotechnologySmall Cap

Medi Caps Limited · Face value ₹10 · Listed Oct 1987
Last close ₹24.68up ₹0.69 (2.88%)BSE ₹24.84

Share price at the NSE close on 28 Oct 2026. Previous close ₹23.99.

28 Oct: open ₹24.99, high ₹24.99, low ₹22.80

52-week range of BSE trades to 28 Oct 2026
₹21.00Low, 11 Mar 2026₹44.70High, 29 Oct 2025
Market cap
₹31 Cr3,735th largest listed
P/E
Lossover the last 12 months
P/B
0.28
Dividend yield
Nonein the last 12 months
ROE
−1.5%
ROCE
−8.7%
Debt to equity
0.00
Volume, NSE
28,257

Medi Caps filed its Q1 results for the quarter to Jun 2026 on 6 Aug 2026 at 5:16 pm, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.Medi Caps annual results and balance sheet

Revenue
₹2.79 Cr+3.7% on a year ago · −19.2% on the quarter before
Operating profit
−₹1.83 Cr
Net profit
−₹2.23 Cr
Earnings per share
−₹1.79
Operating margin
−65.7%
Net margin
−80.1%

From revenue to net profit, ₹ crore

  1. Revenue2.8
  2. Materials and goods−1.3
  3. Employee costs−1.9
  4. Other expenses−1.4
  5. Operating profit−1.8
  6. Depreciation−0.5
  7. Other income+0.1
  8. Finance costs0.0
  9. Profit before tax−2.2
  10. Tax0.0
  11. Net profit−2.2

Medi Caps results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
6.00.1Sep 237.1−0.2Dec 237.9−1.1Mar 246.2−0.6Jun 248.30.3Sep 244.0−2.0Dec 247.01.7Mar 252.7−3.5Jun 252.0−1.8Sep 254.3−0.8Dec 253.43.0Mar 262.8−2.2Jun 26
Peak revenue ₹8.30 Cr, quarter to Sep 2024; lowest ₹2.01 Cr, quarter to Sep 2025A loss in the quarter to Jun 2026, −₹2.23 Cr

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
88.2%−144.8%8.2%9.9%−6.4%−4.5%5.4%−44.2%−3.2%−125.7%−144.8%−24.6%−59.7%−65.7%1.9%−2.3%−13.7%−9.0%3.8%−50.8%24.7%−129.9%−90.5%−17.8%88.2%−80.1%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Sep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Mar 2025Q4Jun 2025Q1Filed 5 AugSep 2025Q2Filed 12 NovDec 2025Q3Filed 11 FebMar 2026Q4Filed 21 MayJun 2026Q1Filed 6 Aug
Revenue from operations17.317.817.612.415.411.010.66.46.07.17.96.28.34.07.02.72.04.33.42.8
13.715.417.111.613.69.49.87.15.56.48.46.57.85.87.26.14.95.45.54.6
Materials and goods bought7.17.86.56.17.75.43.72.91.72.12.72.13.91.92.81.60.61.91.51.3
Employee costs1.92.02.21.71.91.92.21.81.71.52.11.71.91.82.21.91.91.92.21.9
Other expenses4.75.68.43.74.02.13.82.42.12.83.62.72.02.12.22.62.51.61.81.4
Operating profit before depreciation3.62.30.40.81.81.70.8−0.70.50.7−0.5−0.30.5−1.8−0.2−3.4−2.9−1.1−2.1−1.8
Operating margin20.6%13.2%2.4%6.8%11.6%15.1%7.3%−11.4%8.2%9.9%−6.4%−4.5%5.4%−44.2%−3.2%−125.7%−144.8%−24.6%−59.7%−65.7%
Depreciation and amortisation0.50.50.40.50.50.50.20.50.50.50.30.40.40.40.40.40.40.40.50.5
Other income0.10.21.40.30.90.20.20.10.10.10.20.10.30.22.10.31.50.85.60.1
Finance costs0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
One-off items0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Profit before tax3.22.11.50.62.21.30.8−1.10.10.3−0.6−0.60.3−2.01.4−3.5−1.8−0.73.0−2.2
0.00.00.00.00.02.60.40.00.00.50.50.00.00.0−0.30.00.00.00.00.0
Tax rate0.0%0.0%1.0%0.0%0.0%197.0%52.7%–0.0%148.1%––0.0%–−18.6%–––−0.5%–
Profit from discontinued businesses0.00.00.00.00.00.00.0–––––––––––––
3.22.01.50.62.1−1.30.4−1.10.1−0.2−1.1−0.60.3−2.01.7−3.5−1.8−0.83.0−2.2
Other comprehensive income0.8−0.30.2−0.50.30.50.21.11.21.41.01.61.4−0.5−1.61.5−0.90.6−7.94.5
Total comprehensive income4.01.81.70.12.4−0.80.60.01.31.2−0.11.01.7−2.60.1−2.0−2.7−0.2−4.82.2
Net margin18.4%11.5%8.5%4.8%13.9%−12.1%3.4%−17.5%1.9%−2.3%−13.7%−9.0%3.8%−50.8%24.7%−129.9%−90.5%−17.8%88.2%−80.1%
Earnings per share₹2.56₹1.64₹1.20₹0.48₹1.72−₹1.07₹0.29−₹0.89₹0.09−₹0.13−₹0.86−₹0.45₹0.25−₹1.64₹1.38−₹2.80−₹1.46−₹0.61₹2.44−₹1.79
Earnings per share in rupees, restated for later splits and bonuses.

Segment results by quarter

Consolidated, ₹ crore, quarters to Jun 2026.Medi Caps segment results by year

  • Pharma Devision

    Revenue, ₹ crore
    Profit, ₹ crore
  • Real Estate Devision

    Revenue, ₹ crore
    Profit, ₹ crore
  • Other

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue of all businesses6.17.28.16.28.34.07.02.72.04.33.42.8
Company revenue, as in its results6.07.17.96.28.34.07.02.72.04.33.42.8
Revenue4.0–6.05.97.33.86.12.71.03.52.92.7
Revenue growth−74.6%–−44.0%−8.0%84.3%–1.1%−54.5%−86.2%−6.3%−52.0%−0.2%
Profit−1.8–−1.7−0.2−0.1−1.81.0−3.1−2.1−1.13.4−1.6
Profit growth––––––––––223.5%–
Margin−45.7%–−28.8%−3.8%−1.8%−47.3%17.1%−114.7%−208.2%−29.8%115.0%−61.3%
Assets61.8–59.260.660.758.857.454.953.051.548.145.6
Liabilities5.3–4.75.24.54.63.53.14.03.23.22.3
Capital employed56.5–54.555.456.254.353.951.849.048.344.943.3
Revenue2.13.02.10.31.00.30.90.01.00.80.50.1
0.00.00.00.00.00.00.00.00.00.00.00.0
Revenue–4.1––––––––––
Profit is before tax and finance costs, the way companies report their segments.